Lung Cancer: The #1 Cause of Cancer Death

Smoking will kill up to a billion people worldwide this century according to a report published in 2008 by the World Health Organization.


Earlier, More Accurate Detection Saves Lives

The overall 5-year survival rate for Non-Small Cell Lung Cancer (NSCLC), which accounts for over 85% of total lung cancer cases, has risen from only 12% to 16% in the past four decades. Only 30% of NSCLC diagnoses are caught before progressing to later stages of growth, contributing to the gap between the prevailing survival rate and the best case survival rate. Properly treated early stage NSCLC has a 5-year survival rate variously cited to be as high as 80%. Early diagnosis and proper treatment are more important for NSCLC than any other cancer.


Featured News

The American Society of Clinical Oncology (ASCO) Recognizes Gensignia's Research in Lung Cancer Screening
Release Date: Jan 22 2015


MicroRNA Signature Classifiers

Our focus is the development and commercialization of proprietary blood-based oncology tests that detect cancer earlier with greater accuracy. We are developing proprietary miRNA tests to be offered through GENSIGNIA's clinical laboratory.